Krilogy Financial LLC Cara Therapeutics, Inc. Transaction History

Krilogy Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $8,615 - $16,241	-692 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$17.57 - $23.95 $12,158 - $16,573	692 New	692 $17,000
Q2 2018 Aug 15, 2018	SELL	$11.6 - $19.27 $5,185 - $8,613	-447 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$11.77 - $16.08 $2,354 - $3,215	-200 Reduced 30.91%	447 $6,000
Q2 2017 Aug 15, 2017	BUY	N/A	647	647 $10,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.